HIV Antiretroviral Drugs Trigger Stress Granule Formation in Differentiating Oligodendrocytes

This 43-minute research presentation by Eliana Von Krusenstiern from the University of Pennsylvania explores how HIV antiretroviral drugs affect oligodendrocytes during differentiation by triggering stress granule formation. Discover the neurological implications of HIV treatments through cutting-edge research presented at Johns Hopkins Medicine. Learn about the intersection of HIV medication and brain cell development, with particular focus on the cellular stress response mechanisms. Gain insights into this important area of neuroHIV research that has significant implications for understanding treatment side effects in patients receiving antiretroviral therapy.